Skip to main content
. 2016 Nov 7;7(52):85917–85928. doi: 10.18632/oncotarget.13185

Table 1. Matched variables in GC drug-use and non-use patient.

Before matching After matching
Not used Used p Not used Used p
N 1340 139 504 126
Progressed 77 (28.1) 104 (74.8) < 0.001 143 (28.4) 96 (76.2) < 0.001
Age (mean ± SD), years 68.34 ± 12.48 64.60 ± 12.88 < 0.001 64.82 ± 13.01 64.42 ± 12.39 0.75
Male gender (N, %) 528 (39.4) 59 (42.5) 0.49 214 (42.5) 51 (40.5) 0.69
Female gender (N, %) 812 (60.6) 80 (57.5.) 290 (57.5) 75 (59.5)
Diabetes (N, %) 213 (15.9) 22 (15.8) 0.98 63 (12.5) 17 (13.5) 0.76
Hypertensive heart disease (N, %) 65 (4.9) 4 (2.9) 0.29 17 (3.4) 3 (2.4) 0.57
Kidney disease (N, %) 58 (4.3) 6 (4.3) 0.99 16 (3.2) 5 (4.0) 0.66
Chronic respiratory conditions (N, %) 504 (37.6) 65 (46.8) 0.03 230 (45.6) 61 (48.4) 0.58
Metastasis (N, %) 955 (71.3) 128 (92.1) < 0.001 461 (91.5) 115 (91.3) 0.94
Endotracheal Intubation (N, %) 31 (2.3) 19 (13.7) < 0.001 16 (3.2) 6 (4.8) 0.39

Data are number of patients (%), unless otherwise stated. Diabetes, ICD-9-CM 250; hypertensive heart disease, ICD-9-CM 402–404; kidney disease, ICD-9-CM 580–588; chronic respiratory conditions (including chronic obstructive pulmonary disease, asthma, and bronchitis), ICD-9-CM 490–519; metastasis, ICD-9-CM-196-198. endotracheal intubation, NHI operation code 47031C.